FendX Technologies Inc.

Home
Canada
Vancouver, BC
FendX Technologies Inc.

A nanotechnology company developing products that reduce the transmission of pathogens.

04/30/2026

FendX has engaged Innovotech to provide a summary of the potential FDA regulatory pathway for its coated Foley catheter. This activity will support continued development of FendX’s technology being designed to reduce bacteria growth and infection risk.

NEWS RELEASE: https://fendxtech.com/news/

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

04/16/2026

A quick look at FendX and our focus on surface protection and microbial contamination detection.

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

04/15/2026

FendX Technologies engages Galenvs Sciences to establish the manufacturing process for FendX’s liquid surface coating, including producing three pilot lots to assess consistency across batches — a key step toward commercialization.

NEWS RELEASE: https://fendxtech.com/news/

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

03/31/2026

FendX is building strong momentum across its surface protection platform. Our new liquid coating is showing promising antimicrobial performance and durability, while development of our Foley catheter coating aimed at reducing bacterial adhesion continues to advance. We’re also expanding into digital health with an AI driven microbial contamination detection app. Together, these programs reflect our focus on scalable technologies that can make everyday environments safer.

NEWS RELEASE: https://fendxtech.com/news/

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

01/23/2026

FendX Technologies has entered into a collaboration agreement with Aquaox, a U.S.-based maker of environmentally responsible disinfectants, formalizing the first phase of work outlined in their November 2025 MOU. The initial phase will assess technical feasibility and the ability to reliably formulate antimicrobial agents, with the potential to advance toward new agents for future product development. Dr. Carolyn Myers says this marks a meaningful next step in evaluating antimicrobial solutions for FendX’s innovation pipeline.

NEWS RELEASE: https://fendxtech.com/news/

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

01/20/2026

FendX is attending the 3rd Annual Dealflow Discovery Conference, January 28-29, 2026. CEO Carolyn Myers will deliver a presentation and meet one-on-one with investors to discuss recent progress, plans for 2026 and investment opportunities.

NEWS RELEASE: https://fendxtech.com/news/

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

11/25/2025

In partnership with FendX, Dr. Sara Imani, a post-doctoral fellow at McMaster University, has received the Mitacs Innovation Award for advancing an antimicrobial surface coating.

Applied with a brush or roller, this coating provides long-lasting protection by continuously eliminating harmful pathogens.

The award highlights her impactful research and collaboration with FendX to drive public health innovation.

FendX plans to scale up production and finalize the product for market launch in early 2027.

LEARN MORE: https://www.eng.mcmaster.ca/mech/news/postdoctoral-fellow-sara-imani-honoured-with-mitacs-innovation-award/

11/18/2025

FendX Technologies has signed an MOU with Aquaox to formulate eco-friendly pathogen-eliminating agents for FendX to develop new disinfectant products, expanding FendX’s pipeline and IP portfolio.

NEWS RELEASE: https://fendxtech.com/news/

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

08/26/2025

A provisional patent application was filed with USPTO for a novel medical catheter coating designed to reduce microbial growth and improve patient comfort during insertion. This innovation will join FendX Technologies’ expanding portfolio of hygiene-related technologies aimed at lowering infection risks.

NEWS RELEASE: https://fendxtech.com/news/

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

08/20/2025

Provisional patent for an AI-powered app to detect pathogens in real time using a mobile device has been filed by FendX CEO Dr. Carolyn Myers.

NEWS RELEASE: https://fendxtech.com/news/

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

07/09/2025

FendX Technologies is excited to share that REPELWRAP™ film maintained its repelling performance and durability in a second real-world test.

“We are very encouraged by the continued successful performance of REPELWRAP™ film in real-world conditions,” said Dr. Carolyn Myers, our CEO. “These results support the promise of our technology, and we are now evaluating potential next steps in its development.”

At FendX, we are dedicated to developing innovative surface protection products to help build a cleaner, safer world. Follow us for more updates!

Address

701 W. Georgia Street, Suite 1500
Vancouver, BC
L7Y1C6

Website

https://fendxtech.com/

Alerts

Be the first to know and let us send you an email when FendX Technologies Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to FendX Technologies Inc.:

Shortcuts

Want your practice to be the top-listed Clinic in Vancouver?